Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Cutting Edge: MicroRNA-223 Regulates Myeloid Dendritic Cell-Driven Th17 Responses in Experimental Autoimmune Encephalomyelitis.
Therapeutic satisfaction and subjective effects of different strains of pharmaceutical-grade cannabis.
Quantitative assessment of upper limb motor function in Multiple Sclerosis using an instrumented Action Research Arm Test.
Severe Bilateral Heterotopic Ossification in a Patient With Multiple Sclerosis.
Downregulation of cystathionine β-synthase/hydrogen sulfide contributes to rotenone-induced microglia polarization toward M1 type.
Never-resting microglia: physiological roles in the healthy brain and pathological implications.
Elevated plasma high-mobility group box 1 protein is a potential marker for neuromyelitis optica.
Exercise in the community for people with minimal gait impairment due to MS: an assessor-blind randomized controlled trial.
[Neurology at the border of centuries: achievements and prospects].
The Falls Efficacy Scale International: A Cross-Sectional Validation in People with Multiple Sclerosis.
MR imaging and cognitive correlates of relapsing-remitting multiple sclerosis patients with cerebellar symptoms.
The Hygiene Theory Harnessing Helminths and Their Ova to Treat Autoimmunity.
Multiple sclerosis: from molecules to treatment.
Intention tremor and deficits of sensory feedback control in multiple sclerosis: a pilot study.
Treadmill Training or Progressive Strength Training to Improve Walking in People with Multiple Sclerosis? A Randomized Parallel Group Trial.
Cerebral white matter disease in patients with malignancy: pml versus toxic leucoencephalopathy due to chemotherapy.
Potential disease-modifying effects of selective serotonin reuptake inhibitors in multiple sclerosis: systematic review and meta-analysis.
Glycopeptide-based antibody detection in multiple sclerosis by surface plasmon resonance.
IL-17: A new actor in IFN-driven systemic autoimmune diseases.
Multiple sclerosis-linked and interferon-beta-regulated gene expression in plasmacytoid dendritic cells.
[Expression of human B-cell specific receptor FCRL1 in normal individuals and in patients with autoimmune diseases].
Abnormal NMDA receptor function exacerbates experimental autoimmune encephalomyelitis.
Microcystic macular oedema, thickness of the inner nuclear layer of the retina, and disease characteristics in multiple sclerosis: a retrospective study.
Regulation of cerebrospinal fluid (CSF) flow in neurodegenerative, neurovascular and neuroinflammatory disease.
Neuromyelitis optica spectrum disorders: comparison of clinical and magnetic resonance imaging characteristics of AQP4-IgG versus MOG-IgG seropositive cases in the Netherlands.
Pages
« first
‹ previous
…
338
339
340
341
342
343
344
345
346
…
next ›
last »